A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase III Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia

Trial Profile

A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase III Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Dec 2014

At a glance

  • Drugs Rosuvastatin (Primary) ; Valsartan (Primary)
  • Indications Hypercholesterolaemia; Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors LG Life Sciences
  • Most Recent Events

    • 09 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top